Costain wins Crossrail contract for works on London's Bond Street station

Engineering group Costain has scored a 110m pound contract from Crossrail to construct the main works at London's Bond Street station.

Engineering group Costain has scored a 110m pound contract from Crossrail to construct the main works at London's Bond Street station.

In a joint venture with Skanska, the two will work on the platform fit-out and mechanical and electrical services for the Western Ticket Hall in Davies Street and the Eastern Ticket Hall in Hanover Square.

Work will commence this month and is expected to be completed in February 2017 ahead of Crossrail's opening in 2018.

It follows on from the contract already awarded to the joint venture and the announcement in March 2011 for the initial construction of the structure of the station.

"This contract awarded to Costain by Crossrail is, we believe, further demonstration of the successful implementation of our 'Choosing Costain' strategy, in which we focus on building long term relationships with and winning repeat works from blue chip customers who are spending billions on meeting vital infrastructure needs," Chief Executive of Costain, Andrew Wyllie said.

"This contract further contributes to the strength of our order book, which comprises approximately 90% repeat business."

Shares rose 3.90% to 273.25p at 9:30 Monday.

RD

Recommended

Three high-quality FTSE 100 shares going cheap
Share tips

Three high-quality FTSE 100 shares going cheap

As stockmarkets continue to fall, bargains are starting to appear, says Rupert Hargreaves. Here, he picks three high-quality FTSE 100 shares that are …
23 May 2022
Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022